Helen Torley
Fortuna: 51 M $ al 31/05/2026
Fortuna: 51 M $ al 31/05/2026
Helen I. Torley ocupa el cargo de Presidenta, Directora General y Directora de Halozyme Therapeutics, Inc. También forma parte del consejo de Quest Diagnostics, Inc. y es directora y miembro del consejo de administración de la sección de salud de la Organización de Innovación Biotecnológica y miembro del Real Colegio de Médicos. En el pasado fue Vicepresidenta y Directora General de Salud Ósea de Estados Unidos en Amgen, Inc. y Directora Comercial y Vicepresidenta Ejecutiva de Onyx Pharmaceuticals, Inc. (una filial de Amgen, Inc.), Vicepresidenta de Asuntos Médicos de Novartis, Inc., Vicepresidenta de Asuntos Médicos de Sandoz SA y Vicepresidenta de Ventas Cardiovasculares y Metabólicas del Grupo Mundial de Medicamentos de Bristol-Myers Squibb. Se licenció en la Universidad de Glasgow.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 03/06/2026 | 767.780 ( 0,65 % ) | 51 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director Ejecutivo | 06/01/2014 |
| ANTARES PHARMA, INC. | Director/Miembro de la Junta | 24/05/2022 |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| QUEST DIAGNOSTICS INCORPORATED | Director/Miembro de la Junta | 18/05/2022 |
| RELYPSA INC | Director/Miembro de la Junta | 01/09/2016 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Director de Operaciones | 15/12/2011 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2002 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Quest Diagnostics, Inc.
Quest Diagnostics, Inc. Services to the Health IndustryHealth Services Provides diagnostic testing and information services | Health Services |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Sandoz SA |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.